infliximab
Showing 51 - 75 of 168
Ulcerative Colitis, Efficacy, Self, Biologics Trial in China (Infliximab, Vedolizumab, Mesalazine)
Not yet recruiting
- Ulcerative Colitis
- +3 more
- Infliximab
- +2 more
-
Chongqing, Chongqing, China
- +10 more
Jan 11, 2022
Ulcerative Colitis Trial in France (Infliximab, Vedolizumab Injection)
Recruiting
- Ulcerative Colitis
- Infliximab
- Vedolizumab Injection
-
Vannes, Bretagne, France
- +19 more
Jan 5, 2021
IBD, Crohn Disease, Polyunsaturated Acid Lipidosis Trial (azathioprine, infliximab, N-3 Polyunsaturated Fatty Acids)
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- azathioprine
- +2 more
- (no location specified)
Feb 18, 2021
Remsima® in Treatment of Inflammatory Bowel Diseases Among Saudi
Completed
- Inflammatory Bowel Diseases
- +3 more
- Infliximab
-
Jeddah, Saudi Arabia
- +3 more
Feb 22, 2021
Hepatosplenic T-Cell Lymphoma Trial in Norfolk (Infliximab, Golimumab)
Completed
- Hepatosplenic T-Cell Lymphoma
- Infliximab
- Golimumab
-
Norfolk, Virginia(unnamed)
Feb 12, 2021
Breg and Treg With Clinical Effects of Infliximab in Treatment
Completed
- Crohn Disease
- Infliximab
-
Wenzhou, Zhejiang, ChinaSAHWenzhouMU
Feb 13, 2020
IBD Trial in Canada, United States (Infliximab)
Terminated
- Inflammatory Bowel Diseases
- Infliximab
-
Phoenix, Arizona
- +35 more
Jul 28, 2020
Participants Receiving Flixabi or Imraldi: a French Cohort Study
Completed
- Arthritis, Rheumatoid
- +4 more
- Infliximab
- Adalimumab
-
Caluire et Cuire, Auvergne-Rhône-Alpes, France
- +59 more
Oct 17, 2022
Mucocutaneous Lymph Node Syndrome Trial in United States (IVIG, Infliximab)
Completed
- Mucocutaneous Lymph Node Syndrome
- IVIG
- Infliximab
-
Birmingham, Alabama
- +28 more
Nov 5, 2021
IBD Trial in Assiut (Infliximab)
Unknown status
- Inflammatory Bowel Diseases
- Infliximab
-
Assiut, EgyptHyam Fathy
Jul 14, 2020
Ulcerative Colitis Trial in Worldwide (Etrolizumab, Infliximab, Placebo (IV))
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Completed
- Colitis, Ulcerative
- Bowel Diseases, Inflammatory
- Infliximab
-
Hartford, Connecticut
- +6 more
Apr 8, 2020
Dermatomyositis, Polymyositis Trial run by the NIAMS (Infliximab)
Completed
- Dermatomyositis
- Polymyositis
- Infliximab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 30, 2019
(CHOIR)
Recruiting
- Chronic Nonbacterial Osteomyelitis
- Chronic Recurrent Multifocal Osteomyelitis
- Methotrexate
- +9 more
-
Seattle, WashingtonSeattle Children's Hospital
Jan 25, 2021
Behcet Disease Trial in Korea, Republic of (Infliximab)
Completed
- Behcet Disease
- Infliximab
-
Busan, Korea, Republic of
- +4 more
Oct 16, 2019
Rheumatoid Arthritis Trial in United States (Infliximab, Methotrexate, Methylprednisolone)
Terminated
- Rheumatoid Arthritis
- Infliximab
- +4 more
-
Birmingham, Alabama
- +52 more
Oct 13, 2020
Rheumatoid Arthritis Trial in Leeds (Infliximab, Methylprednisolone, Methotrexate)
Completed
- Rheumatoid Arthritis
- Infliximab
- +3 more
-
Leeds, West Yorkshire, United KingdomChapel Allerton Hospital
Oct 30, 2019
Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma
Recruiting
- Clinical Stage 0 Cutaneous Melanoma AJCC v8
- +43 more
- Best Practice
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Crohn's Disease Trial in Portland (Infliximab)
Withdrawn
- Crohn's Disease
- Infliximab
-
Portland, OregonOregon Health & Science University
May 6, 2019
Reperfusion Injury Trial in Leuven (Antithrombin-III, Infliximab, Apotransferrin)
Completed
- Reperfusion Injury
- Antithrombin-III
- +9 more
-
Leuven, BelgiumUniversity Hospitals Leuven
Aug 8, 2019